ISU ABXIS

ISU ABXIS focuses on the development of therapeutic antibodies for antithrombotic, anti-inflammatory, anticancer, and rare disease treatments. It has established a variety of new drug pipelines, including immunotherapeutic anticancer agents and treatments for intractable diseases. As a specialized biopharmaceutical company, ISU ABXIS leads the biotechnology industry in China. The company also provides medical services such as cancer drug sensitivity testing and genetic testing. Through its antibody development technology, Young-Appjis offers new treatment options to cancer and rare disease patients worldwide, enhancing their quality of life and convenience, fulfilling ISU ABXIS's vision as a global biotech company to create a better future.